A detailed history of Ameriprise Financial Inc transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Ameriprise Financial Inc holds 958,270 shares of DGX stock, worth $131 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
958,270
Previous 785,109 22.06%
Holding current value
$131 Million
Previous $107 Million 22.24%
% of portfolio
0.03%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$137.09 - $137.09 $23.7 Million - $23.7 Million
173,161 Added 22.06%
958,270 $131 Million
Q2 2024

Aug 14, 2024

SELL
$125.91 - $144.34 $1.07 Million - $1.23 Million
-8,513 Reduced 1.07%
785,109 $107 Million
Q1 2024

May 15, 2024

SELL
$123.78 - $142.11 $28 Million - $32.2 Million
-226,438 Reduced 22.2%
793,622 $106 Million
Q4 2023

Feb 14, 2024

BUY
$120.62 - $141.12 $7.2 Million - $8.43 Million
59,717 Added 6.22%
1,020,060 $141 Million
Q3 2023

Nov 14, 2023

BUY
$121.86 - $144.92 $9.8 Million - $11.7 Million
80,436 Added 9.14%
960,343 $117 Million
Q2 2023

Aug 14, 2023

BUY
$130.56 - $146.84 $7.04 Million - $7.91 Million
53,897 Added 6.52%
879,907 $124 Million
Q1 2023

May 15, 2023

SELL
$131.53 - $155.76 $14.2 Million - $16.8 Million
-107,744 Reduced 11.54%
826,010 $117 Million
Q4 2022

Feb 14, 2023

BUY
$123.31 - $157.26 $8.04 Million - $10.3 Million
65,201 Added 7.51%
933,754 $146 Million
Q3 2022

Nov 14, 2022

SELL
$121.77 - $141.1 $8.41 Million - $9.75 Million
-69,091 Reduced 7.37%
868,553 $107 Million
Q2 2022

Aug 15, 2022

BUY
$127.07 - $145.39 $18.2 Million - $20.9 Million
143,529 Added 18.07%
937,644 $124 Million
Q1 2022

May 16, 2022

BUY
$129.09 - $164.35 $4.88 Million - $6.22 Million
37,838 Added 5.0%
794,115 $108 Million
Q4 2021

Feb 14, 2022

BUY
$140.36 - $173.01 $2.93 Million - $3.61 Million
20,868 Added 2.84%
756,277 $129 Million
Q3 2021

Nov 15, 2021

SELL
$132.95 - $158.0 $6.94 Million - $8.24 Million
-52,183 Reduced 6.63%
735,409 $107 Million
Q2 2021

Aug 16, 2021

BUY
$126.66 - $141.48 $3.5 Million - $3.91 Million
27,635 Added 3.64%
787,592 $104 Million
Q1 2021

May 17, 2021

SELL
$114.63 - $133.34 $8.26 Million - $9.61 Million
-72,080 Reduced 8.66%
759,957 $97.5 Million
Q4 2020

Feb 12, 2021

SELL
$112.7 - $128.05 $211 Million - $240 Million
-1,874,206 Reduced 69.25%
832,037 $99.1 Million
Q3 2020

Nov 16, 2020

BUY
$107.05 - $130.01 $14.3 Million - $17.3 Million
133,302 Added 5.18%
2,706,243 $310 Million
Q2 2020

Aug 14, 2020

BUY
$73.34 - $122.61 $148 Million - $247 Million
2,012,681 Added 359.24%
2,572,941 $293 Million
Q1 2020

May 15, 2020

SELL
$75.14 - $115.68 $2.14 Million - $3.3 Million
-28,527 Reduced 4.85%
560,260 $45 Million
Q4 2019

Feb 14, 2020

SELL
$100.29 - $107.99 $3.96 Million - $4.26 Million
-39,438 Reduced 6.28%
588,787 $62.9 Million
Q3 2019

Nov 14, 2019

BUY
$97.85 - $107.42 $943,567 - $1.04 Million
9,643 Added 1.56%
628,225 $67.2 Million
Q2 2019

Aug 14, 2019

BUY
$85.18 - $101.94 $660,059 - $789,933
7,749 Added 1.27%
618,582 $63 Million
Q1 2019

May 15, 2019

SELL
$80.68 - $89.92 $846,655 - $943,620
-10,494 Reduced 1.69%
610,833 $54.9 Million
Q4 2018

Feb 14, 2019

SELL
$79.75 - $108.38 $5.65 Million - $7.67 Million
-70,802 Reduced 10.23%
621,327 $51.7 Million
Q3 2018

Nov 14, 2018

BUY
$105.42 - $114.99 $50.4 Million - $54.9 Million
477,644 Added 222.69%
692,129 $74.7 Million
Q2 2018

Aug 14, 2018

BUY
$97.35 - $113.14 $840,130 - $976,398
8,630 Added 4.19%
214,485 $23.6 Million
Q1 2018

May 15, 2018

BUY
$96.42 - $107.88 $542,266 - $606,717
5,624 Added 2.81%
205,855 $20.6 Million
Q4 2017

Feb 12, 2018

BUY
$90.86 - $100.24 $1.44 Million - $1.59 Million
15,826 Added 8.58%
200,231 $19.7 Million
Q3 2017

Nov 07, 2017

BUY
$91.96 - $108.35 $17 Million - $20 Million
184,405
184,405 $17.3 Million

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.